Gingicaine Gel, Mint Julep Gel
Product Images NDC 10129-063

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gingicaine Gel, Mint Julep (NDC 10129-063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Allergy Alert

This image shows an allergy alert warning advising not to use the product if there is a history of allergy to any "caine" local anesthetics. The text is clear and focused on allergy information related to the product's anesthetic components.*

FDA Label Image

Keep Out Of Reach Of Children (Children Page 001)

Warning text panel for GingiCaine Gel, Mint Julep Gel instructs to keep the product out of reach of children and to call a doctor immediately if ingested or swallowed by a child, with directions to follow accordingly.*

FDA Label Image

Contraindications

A text panel describing contraindications for GingiCaine Gel, Mint Julep. It specifies that the gel should not be used in patients with hypersensitivity to ester-type local anesthetics and is not for use in teething or children under 2 years old.*

FDA Label Image

Active Ingredient (Gingicaine Active Ingredients 001)

This drug facts panel lists the active ingredient as Benzocaine 20% w/v, designated as the oral anesthetic purpose. It is a text excerpt showing the key active ingredient and its intended use in the product.*

FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

A section of a drug label or instructions panel showing a storage warning. The text advises to avoid excessive heat above 40 °C (104 °F).*

FDA Label Image

Consult A Doctor Promptly (Gingicaine Consult A Doctor)

This text panel provides warnings and instructions for GingiCaine Gel, Mint Julep flavor, advising to consult a doctor if sore throat symptoms worsen or last more than 2 days, or if accompanied by other symptoms. It also cautions against eye contact, keeping the product out of children's reach, and seeking help if excessive amounts are swallowed, emphasizing not to exceed the recommended dosage.*

FDA Label Image

Dosage And Administration001 (Gingicaine Dosage And Admin 001)

A partial text panel titled 'Dosage & Administration' advising that mucosa should be dried prior to application and excess saliva removed before using the product. The text appears to be part of the instructions for use of GingiCaine Gel, Mint Julep Flavor.*

FDA Label Image

Dosage And Administration002 (Gingicaine Dosage And Admin 002)

A text panel providing application instructions for a dental anesthetic gel. It includes guidance on minimizing dilution with cotton rolls or saliva ejectors, proper use of sterile cotton or gauze, dosage limits, application frequency (up to 4 times daily), and age recommendations for use in adults and children 2 years and older, with a caution for children under 2 to consult a dentist or doctor.*

FDA Label Image

Indications (Gingicaine Indications 001)

The image shows a section of a drug facts or indications panel describing the use of GingiCaine Gel. It states the gel is indicated for anesthesia of mucous membranes of the oropharynx, minimizing pain related to ulcers, needle puncture, deep scaling, and application of matrix bands, as well as aiding in impressions or intraoral radiographs for patients with excessive gag reflex.*

FDA Label Image

Precautions (Gingicaine Precaution 001)

A text panel titled 'Precautions' detailing dental usage guidelines for local anesthetics, advising dentists to avoid applying to severely traumatized mucosal areas and certain pharynx areas, cautioning use in patients with drug sensitivities, and warning against contact with local anesthetics to prevent sensitization.*

FDA Label Image

Uses (Gingicaine Uses 001)

A drug facts text panel listing the uses of GingiCaine Gel, Mint Julep flavor. It states the gel is used to reduce pain or discomfort caused by minor dental procedures, minor gum injury, canker sores, sore throat, and minor mouth or gum irritations caused by dentures or orthodontic appliances.*

FDA Label Image

Inactive Ingredient (Inactive Ingredient Page 001)

A text panel listing inactive ingredients of the product. It includes Polyethylene Glycol 3350, Polyethylene Glycol 400, and Potassium Sodium Saccharate. No other text or product information is visible.*

FDA Label Image

Mint Julep Jar Label

Drug Facts panel for GingiCaine Gel, Mint Julep flavored topical anesthetic gel containing 20% benzocaine as the active ingredient. The panel includes information on uses, allergy alert, warnings, directions for use, dosage and administration, and manufacturer details, Gingi-Pak. The label advises use for oral pain relief related to dental procedures and minor mouth irritations, with safety and application precautions.*

FDA Label Image

Purpose (Purpose Page 001)

A text panel containing a brief description of GingiCaine Gel as a topical anesthetic used by dentists just prior to an injection. It mentions that GingiCaine is usually spread on a patient's gum.*

FDA Label Image

Warnings

Warning text panel from GingiCaine Gel, Mint Julep flavor, indicating the product is for external use only. It notes a rare but serious risk of methemoglobinemia, with symptoms including pale or blue-tinged skin, headache, rapid heart rate, shortness of breath, dizziness, fatigue, and advises against use in children under 2 years. It instructs to cease use and seek medical attention if symptoms develop.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.